About Robert Cascella
Robert Cascella is a director at Celestica.
Form D filings name Robert Cascella as a director at Metabolon.
Robert Cascella reports to the SEC as a director or officer of 6 public companies, including KORU Medical Systems (KRMD), Neuronetics (STIM) and Mirion Technologies (MIR).
Robert Cascella first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Cascella in the role, so the role may have started earlier or lasted longer.
CI
Celestica Inc.
Director
2024 – 2026 · Public company (CLS)
KI
KORU Medical Systems, Inc.
Director
2022 – 2026 · Public company (KRMD)
NI
Neuronetics, Inc.
Director
2021 – 2026 · Public company (STIM)
MI
Mirion Technologies, Inc.
Director
2021 – 2026 · Public company (MIR)
HI
Hologic Inc.
CEO and President, director
2006 – 2013 · Public company (HOLX)
TI
Third Wave Technologies Inc.
Director
2008 · Public company (TWTI)
Key Colleagues at Startups
The people Robert Cascella works with at each company, as listed on that company's latest Form D.
Metabolon, Inc. · Form D, Jan 10, 2025
GI
Gerald Haines II
Executive officer
JO
John Oxaal
Director
JL
Jan Lundberg
Director
RB
R. Barry
Director
RF
R. Fletcher
Director
RH
Rohan Hastie
Chief Executive Officer and director
TS
Todd Schermerhorn
Director